- World Pharma News Home » Published News » Product
(a free service delivered by FeedBurner)
Roche announced that Actemra (tocilizumab) can significantly inhibit structura[1] damage to joints in patients with rheumatoid arthritis (RA), a critical measure of effectiveness of an RA treatment.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer Schering Pharma's new low-dose oral contraceptive YAZ® has been approved in the EU. YAZ® will be the first oral contraceptive on the European market containing the unique progestin drospirenon
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Boehringer Ingelheim announced that the European Commission has given the full marketing authorisation to its HIV protease inhibitor (PI), Aptivus® (tipranavir). The Commission has fully approved Apt
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
H. Lundbeck A/S and Neurim Pharmaceuticals Ltd. announced that Lundbeck has obtained expanded exclusive rights to commercialize Circadin® in Asia, Latin America and other major markets such as Austra
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca today announced submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) to seek approval of a new indication for SYMBICORT® (budesonide/formo
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The European Commission has extended the marketing authorization for Zevalin® ([90Y]-ibritumomab tiuxetan) in Europe. Zevalin can now be used in the course of a first-line therapy after remission ind
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The European Medicines Agency (EMEA) has recommended that the product information of all centrally authorised angiotensin II receptor antagonists be harmonised, regarding their use during pregnancy.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novartis has announced a 20% average reduction in the price of Coartem® tablets (artemether/lumefantrine 20 mg/120 mg), the state-of-the-art artemisinin-based combination treatment (ACT) for malaria.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer confirmed that Bayer Schering Pharma AG and Bayer HealthCare Pharmaceuticals Inc. filed a patent infringement lawsuit in U.S. Federal Court in the Southern District of New York (New York) again
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
